J Atheroscler Thromb 10:211–225PubMedCrossRef Hoffman M, Monroe DM (2007) Coagulation 2006: a modern view of hemostasis. Hematol Oncol Clin N Am 21:1–11CrossRef Jedinak A, Maliar T, Grancai D, Nagy M (2006) Inhibition activities of natural products on serine proteases. Phytother
Res 20:214–217PubMedCrossRef Li NG, Song SL, Shen MZ, Tang YP, Shi ZH, Tang H, Shi QP, Fu YF, Duan JA (2012) Mannich bases of scutellarein as thrombin-inhibitors: design, synthesis, biological activity and solubility. Bioorg Med Chem 20:6919–6923PubMedCrossRef Lineweaver H, Burk D (1934) The determination of enzyme dissociation constants. J Am Chem Soc 56:658–666CrossRef Liu L, Ma H, Yang N, Tang Y, Guo J, Tao W, Duan J (2010) A series of natural flavonoids as thrombin inhibitors: structure-activity relationships. Thromb Res 126:e365–e378PubMedCrossRef Lottenberg R, Hall JA, Fenton JW, Jackson CM (1982) The action of thrombin AZD1208 manufacturer selleck on peptide p-nitroanilide
substrates: hydrolysis of Tos-Gly-Pro-Arg-pNA and D-Phe-Pip-Arg-pNA by human alpha and gamma and bovine alpha and beta-thrombins. Thromb Res 28:313–332PubMedCrossRef Manach C, Williamson G, Morand C, Scalbert A, Remesy C (2005) Bioavailability and bioefficacy of polyphenols in humans I. Review of 97 bioavailability studies. Am J Clin Nutr 81:230S–242SPubMed Mann KG, Brummel-Ziedins K, Orfeo T, Butenas S (2006) Models of blood coagulation. Blood Cells Mol Dis 36:108–117PubMedCrossRef McMichael M (2012) New models of hemostasis. Top Companion Anim Med 27:40–45PubMedCrossRef Mozzicafreddo M, Cuccioloni M, Eleuteri AM, Fioretti E, Angeletti M (2006) Flavonoids
inhibit the amidolytic activity of human thrombin. Biochimie 88:1297–1306PubMedCrossRef Muszbek L, Yee VC, Hevessy Z (1999) Blood coagulation factor XIII: structure and function. Thromb Res 94:271–305PubMedCrossRef Nowak P, Zbikowska HM, Ponczek M, Kolodziejczyk J, Wachowicz B (2007) Different vulnerability of fibrinogen subunits to oxidative/nitrative modifications Phosphoglycerate kinase induced by peroxynitrite: functional consequences. Thromb Res 121:163–174PubMedCrossRef Ofosu FA (2006) Review: laboratory markers quantifying prothrombin activation and actions of thrombin in venous and arterial thrombosis do not accurately assess disease severity or the effectiveness of treatment. Thromb Haemost 96:568–577PubMed Pawlaczyk I, Czerchawski L, Pilecki W, Lamer-Zarawska E, Gancarz R (2009) Polyphenolic–polysaccharide compounds from selected medicinal plants of Asteraceae and Rosaceae families: chemical characterization and blood anticoagulant activity. Carbohydr Polym 77:568–575CrossRef Pawlaczyk I, Czerchawski L, Kuliczkowski W, Karolko B, Pilecki W, Witkiewicz W, Gancarz R (2011) Anticoagulant and anti-platelet activity of polyphenolic–polysaccharide preparation isolated from the medicinal plant Erigeron canadensis L.